Publications

The 2019 Real-World Evidence and Outcomes-Based Agreements Working Group research and outputs executive summary report is now available. The mission of the Real-World Evidence and Outcomes-Based Agreements Working Group is to advance the opportunity for the use of outcomes-based agreements in Canada.

The 2019 Real-World Evidence and Outcomes-Based Agreements Working Group research and outputs executive summary report is now available. The mission of the Real-World Evidence and Outcomes-Based Agreements Working Group is to advance the opportunity for the use of outcomes-based agreements in Canada.

On September 5th, 2024, Katherine Scott and Lana Duan from MORSE Consulting presented “Accelerating Access: Leveraging Target Zero to Expedite Time to Access for New Therapies” at the CDA-AMC Symposium. They explored how pre-NOC submissions impact market access timelines, using CDA-validated data and insights from our internal database.Download our presentation to learn more about these findings and strategies for accelerating access to new therapies. Panelists We'd like to thank all…

We’re excited to announce that the 2024 Canadian Reimbursement & Forecasting Timelines (CRaFT) Mid-Year Update is now available! If you’re subscribed, you can now access the latest insights and data to enhance your market access strategies here: MORSE Reports Portal Not a subscriber yet? Don’t miss out—subscribe now to stay informed and take advantage of this valuable resource! MORSE Subscriptions

The 2019 Real-World Evidence and Outcomes-Based Agreements Working Group research and outputs executive summary report is now available. The mission of the Real-World Evidence and Outcomes-Based Agreements Working Group is to advance the opportunity for the use of outcomes-based agreements in Canada.

MORSE's Sang Mi Lee joins a podcast with Exactis Innovation discussing the intricacies of Canada's drug reimbursement system and how it might evolve with the recent creation of the Canadian Drug Agency (CDA).   Summary: With national pharmacare closer to reality in Canada, our insightful conversation with market access professionals and seasoned pharmacists, Sang Mi Lee, MBA, BSc Phm, RPh and Brian O’Rourke, sheds light on the intricacies of Canada’s drug reimbursement system…

MORSE Consulting Inc. is pleased to release our pCPA Quarterly Update infographic, which highlights key metrics from Q1 2024 compared to performance over the last year. For a more in-depth look at market access trends and timelines comparing 2023 data to that of the past four years, order MORSE Consulting’s Canadian Reimbursement and Forecasting Timelines (CRaFT) report.   Click on graphic to print or see full-size OR download PDF.  …

At MORSE Consulting, we're delighted to share insights from Sherry O'Quinn's recent participation at the Rare Disease Day 2024 Summit held by the Canadian Organization for Rare Disorders (CORD) in Ottawa. The conference, themed around sustaining the momentum of two decades of impactful work in the rare disease community, was insightful and inspiring.   Sherry had the opportunity to present a snapshot on the timelines to access for drugs for…

The 2019 Real-World Evidence and Outcomes-Based Agreements Working Group research and outputs executive summary report is now available. The mission of the Real-World Evidence and Outcomes-Based Agreements Working Group is to advance the opportunity for the use of outcomes-based agreements in Canada.

MORSE Consulting Inc. is pleased to release our pCPA Quarterly Update infographic highlighting key metrics from Q4 2023 compared to performance over the last year. For a more in-depth look at market access trends and timelines comparing 2022 data to that of the past four years, order MORSE Consulting’s Canadian Reimbursement and Forecasting Timelines (CRaFT) report.   Click on graphic to print or see full-size OR download PDF.   Please…

The 2019 Real-World Evidence and Outcomes-Based Agreements Working Group research and outputs executive summary report is now available. The mission of the Real-World Evidence and Outcomes-Based Agreements Working Group is to advance the opportunity for the use of outcomes-based agreements in Canada.

MORSE Consulting Inc. is pleased to release our pCPA Quarterly Update infographic highlighting key metrics from Q3 2023 compared to performance over the last year. For a more in-depth look at market access trends and timelines comparing 2022 data to that of the past four years, order MORSE Consulting’s Canadian Reimbursement and Forecasting Timelines (CRaFT) report.   Click on graphic to print or see full-size OR download PDF.   Please…

For a more in-depth look at market access trends and timelines comparing 2022 data to that of the past four years, order MORSE Consulting’s Canadian Reimbursement and Forecasting Timelines (CRaFT) report.   Click on graphic to print or see full-size OR download PDF.   Please contact info@morseconsulting.ca regarding any questions on this infographic or on the CRaFT report. Embed this infographic (copy and paste code) on your website with attribution: <p><a href="https://morseconsulting.ca/morse-consulting-releases-its-pcpa-quarterly-update-q2-2023"><img…

For a more in-depth look at market access trends and timelines comparing 2021 data to that of the past four years, order MORSE Consulting’s Canadian Reimbursement and Forecasting Timelines (CRaFT) report.   Click on graphic to print or see full-size OR download PDF.   Please contact info@morseconsulting.ca regarding any questions on this infographic or on the CRaFT report. Embed this infographic (copy and paste code) on your website with attribution: <p><a href="https://morseconsulting.ca/morse-consulting-releases-its-pcpa-quarterly-update-q4-2022"><img…

MORSE has been providing monthly data analytics and expert insights through our pCPA updates since 2017. Starting in 2022, MORSE is now publishing the pCPA updates on a quarterly basis. For a more in-depth look at market access trends and timelines comparing 2021 data to that of the past four years, order MORSE Consulting’s Canadian Reimbursement and Forecasting Timelines (CRaFT) report.   Click on graphic to print or see full-size…